Mgo One Seven LLC Alaunos Therapeutics, Inc. Transaction History

Mgo One Seven LLC

  • $2.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$1.09 - $1.89 $15,478 - $26,838
-14,200 Closed
0 $0
Q2 2021

Jul 29, 2021
SELL
$2.63 - $3.67 $7,890 - $11,010
-3,000 Reduced 17.44%
14,200 $37,000
Q1 2021

Apr 29, 2021
BUY
$2.82 - $5.6 $48,504 - $96,320
17,200 New
17,200 $61,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email